BioMarin Pharmaceutical, Inc. (BMRN)
65.32
-0.30
(-0.45%)
USD |
NASDAQ |
Aug 27, 16:00
65.32
0.00 (0.00%)
After-Hours: 19:28
BioMarin Pharmaceutical EPS Diluted (TTM) : 0.3709 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3709 |
| March 31, 2026 | 1.370 |
| December 31, 2025 | 1.782 |
| September 30, 2025 | 2.669 |
| June 30, 2025 | 3.376 |
| March 31, 2025 | 2.695 |
| December 31, 2024 | 2.199 |
| September 30, 2024 | 1.661 |
| June 30, 2024 | 1.324 |
| March 31, 2024 | 1.068 |
| December 31, 2023 | 0.8712 |
| September 30, 2023 | 0.7637 |
| June 30, 2023 | 0.5167 |
| March 31, 2023 | 0.3721 |
| December 31, 2022 | 0.7303 |
| September 30, 2022 | 0.4162 |
| June 30, 2022 | 0.2528 |
| March 31, 2022 | 0.175 |
| December 31, 2021 | -0.3506 |
| September 30, 2021 | 0.0303 |
| June 30, 2021 | 4.236 |
| March 31, 2021 | 4.004 |
| December 31, 2020 | 4.350 |
| September 30, 2020 | 4.367 |
| June 30, 2020 | 0.6617 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6141 |
| December 31, 2019 | -0.1425 |
| September 30, 2019 | -0.2454 |
| June 30, 2019 | -0.6164 |
| March 31, 2019 | -0.4973 |
| December 31, 2018 | -0.4405 |
| September 30, 2018 | -0.71 |
| June 30, 2018 | -0.71 |
| March 31, 2018 | -0.83 |
| December 31, 2017 | -0.66 |
| September 30, 2017 | -0.90 |
| June 30, 2017 | -1.05 |
| March 31, 2017 | -3.42 |
| December 31, 2016 | -3.84 |
| September 30, 2016 | -2.92 |
| June 30, 2016 | -3.30 |
| March 31, 2016 | -1.23 |
| December 31, 2015 | -1.15 |
| September 30, 2015 | -2.01 |
| June 30, 2015 | -1.36 |
| March 31, 2015 | -1.08 |
| December 31, 2014 | -0.92 |
| September 30, 2014 | -0.89 |
| June 30, 2014 | -1.32 |
| March 31, 2014 | -1.25 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Incyte Corp. | 7.846 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Vertex Pharmaceuticals, Inc. | 17.19 |
| Ionis Pharmaceuticals, Inc. | -3.473 |
| Regeneron Pharmaceuticals, Inc. | 40.46 |